Novak Djokovic announces he has hired longtime rival Andy Murray to be next coachSMArtX Advisory Solutions Unveils Q4 Select List Highlighting Elite Investment Strategies
. The Scottish Government announced that all 31 Health and Social Care Partnerships have now signed up to a programme which supports people experiencing distress. The Distress Brief Intervention (DBI) service was first launched as a pilot seven years ago and provides support to people who present to emergency services or in primary care settings in a distressed state. Since its introduction, more than 75,000 people have been given support as the programme aims to offer people an initial call within 24 hours. They are then provided with up to two weeks of one-to-one support with a specially trained practitioner to help address issues which might be contributing to their distress. Frontline staff in Police Scotland, Scottish Ambulance Service, Accident and Emergency Departments, Primary Care and NHS24 can refer people who present to them in emotional distress. Around 1,700 police officers are now trained to signpost and refer people experiencing mental health distress to the right agency which can provide support. Assistant Chief Constable Catriona Paton said: “Policing is often the first response when people need help. Our mission is to keep people safe and we’ll always respond to threat, harm and risk to ensure public safety. “Our involvement in mental health incidents and supporting vulnerable people has a significant impact on this organisation and is beyond where policing should be. That’s not the best support for those who need help and it’s not delivering best value for the public. “DBI enables trained officers to identify when someone needs support and signpost them to the right service, allowing them to redirect to tackling threat, harm and risk and preventing crime.” Kirstie McCulloch, who received support and now works for DBI said: “I was experiencing severe panic attacks, anxiety, and depression, due to the Covid lockdowns. “NHS 24 helped me when I had a severe panic attack, and I came off the call feeling less distressed. I still needed some support, so I was referred to the DBI service, which in my local area is run by SAMH. “I was a little unsure initially, but the support was invaluable. By the end of the two-week service, I felt I had a better perspective on how to move forward. “I asked my practitioner how they came into the role, and I knew this was something I would like to do for others. “In the 18 months I have worked here, I have delivered compassionate support and helped people get back on their feet. I get huge satisfaction from this role.” Public Health Minister Jenni Minto said: “In developing our world leading DBI programme over 75,000 people across Scotland have received the right support at the right time and in the right place. “This innovative referral pathway and collaborative approach has helped reduce pressures in the Scottish Ambulance Service, A&E and Police Scotland, allowing frontline staff to focus on other responsibilities. “By investing £24m in the programme since 2016, the Scottish Government has ensured a Scotland-wide approach has been taken to help people cope when they are in a distressed state. It is clear that this help provided to people is invaluable.” Professor Rory O’Connor, Professor of Health Psychology at University of Glasgow, said: “DBI is an incredible achievement. Tens of thousands of people in distress have received immediate, compassionate support since its launch in 2017. “DBI is a remarkable team effort by colleagues up and down the country, driven by the shared purpose of delivering compassionate, connected support to people when they need it. I am so proud to be involved in this world-leading mental health intervention.” Get all the latest news from around the country Scan the QR code on your mobile device for all the latest news from around the country
Cat And Horse 'In Love' TikTok Video Goes Viral | WATCHSaginaw County commissioner under fire for Facebook post to face censure vote
GOP Armed Services chair criticizes ban on gender-affirming care for minors in NDAAMy dear 2024, By Dakuku Peterside Letter writing may be a lost art in this digital age, yet there are moments when the weight of reflection demands the intimacy of a letter. So, dear 2024, consider this a heartfelt note from a Nigerian seeking to encapsulate the whirlwind of emotions, events, and transformations that have unfolded over the past twelve months. As I pen down these words, I do so with the awareness that you are not an ordinary year. Your arrival brought hope, but as the days rolled, that hope was replaced with hardship, struggle, perseverance and lessons. In this letter, as tricky as it may be, I will attempt to recount the key events that shaped you – the milestones that defined not only my life but the collective experience of a nation grappling with economic hardship, political uncertainty, and social upheaval. Nigeria stands at a crossroads, and you will be remembered as a year that tested our spirit and resolve. This is not just a recollection of facts but a narrative of survival in a land where, at times, the future seemed uncertain. You were, indeed harsh, but we, the Nigerian people, have shown remarkable resilience and perseverance. Despite the economic hardships you brought, with inflation, unemployment, and rising living costs affecting all, we have stood strong. Your visitation of economic hardships worsened by 34-40% inflation rate and supply chain disruptions, an embarrassing unemployment rate of 40%, and rising living costs affected both the high and the low. Almost all households felt your pinch. Nigeria’s food inflation rate rose to close to 40% by mid-year, pushing millions into poverty. National Bureau of Statistics reports indicated that over 71 million Nigerians faced food insecurity by the third quarter. The exchange rate rose by over 60%. Yet, amid these challenges, the Nigerian people showed remarkable resilience and perseverance. To put it into context, essential commodities such as rice, maize, and garri doubled in price within months. The petrol price fluctuated between ₦700 to ₦1200 per litre, severely impacting transportation and logistics. Even sachet water, popularly called ‘pure water’, became a luxury for many, reflecting the depth of economic strain. You made our economic thinkers and planners look clueless. Thank God we, the people, showed understanding with them. You brought needless political contentions –the Rivers crisis, contentious elections in Edo and Ondo states, the Kano Emir drama, the Old-New-Old national anthem, and “Endbadgovernance”demonstrations. An attempt to reform our tax system highlighted our stubborn ethnic fault lines. You were not short of drama, both relevant and irrelevant. The reinstatement of the old national anthem left citizens divided, as critics viewed it as distracting from pressing governance issues. However, amid these contentions, the Nigerian people stood united, showing remarkable solidarity. Despite the divisive nature of some of these events, we have remained a united front. Poverty and hunger became our companions, resulting in three deadly stampedes during palliative distributions in Oyo, Anambra, and the Federal Capital Territory (FCT), leaving no fewer than 60 people dead. Unemployment among the youth reached over 45%, with many university graduates resorting to menial jobs or leaving the country in search of greener pastures, contributing to the ongoing ‘Japa’ wave. At the global scene, you delivered historic elections and global unrest. People in more than 60 countries—representing almost 50 per cent of the world’s population—went to the polls during the year. Voters in Mexico and the United Kingdom picked new leaders, while a former U.S. president was invited by voters back to the White House. In Nigeria, voter turnout in local elections dipped to a record low of 28%, reflecting growing disillusionment with governance. This disinterest was amplified by widespread insecurity, with over 1,500 reported cases of abduction and banditry disrupting daily life. Villages in Zamfara, Kaduna, and Borno faced relentless attacks, forcing thousands into internally displaced persons (IDP) camps. “Lakurawa” gained a strong foothold in parts of North-West states. Some strange things happened that we did not foresee. Greece extended adoption rights to same-sex couples, and Thailand legalised same-sex marriage, becoming the first country in Southeast Asia to do so. You gave LGBTQ+ rights activists something to celebrate. This felt strange in this part of the world, where same-sex relations remain criminalised, and social acceptance lags far behind. In Nigeria, lawmakers intensified efforts to uphold conservative values, with proposed bills aimed at further restricting LGBTQ+ rights. The disparity in cultural values highlighted the widening gap between regions of the world, reflecting the complex layers of societal evolution. You saw the world in turmoil, and the Russian vs Ukraine war continued unabated. This war brought about lots of military posturing, leading some to fear nuclear conflict between Russia and NATO. The conflict between Israel, Hamas, and Iran ramped up to greater heights. The Middle East is in commotion, with the war extending to Lebanon and Israel vowing not to stop until it wipes Hamas and Hezbollah out. Iran has shown its willingness to confront Israel, framing itself as the watchdog of the Middle East against Israel’s aggression. You also witnessed the collapse of the Assad regime in Syria, raising fears of extremist groups seizing power. Reports from the UN suggested that over 300,000 Syrian refugees fled to neighbouring countries by year-end, adding to the growing refugee crisis. But amid it all, you allowed some of my compatriots to think and look at things differently, to learn that hard work does not kill and bad governance is for a season. Despite the odds, small businesses grew by 7% in sectors like agriculture and technology, offering a glimmer of hope. Despite the increase in tariffs and persistent collapse of the national grid, there has been a marginal improvement in power output in homes and factories. The healthcare sector witnessed significant transformation in the past few months of 2024 because of incisive, superlative reforms and programmes. So far, 53,000 health workers have been re-trained—an impressive number—to deliver integrated, high-quality services. The Maternal and Newborn Mortality Reduction Initiative, which offers free caesarean sections to all eligible Nigerian women meeting the criteria, and the Nigeria Climate Change and Health Vulnerability and Adaptation (V&A) Assessment Report were launched. These initiatives represent a step forward in our healthcare system, offering hope for the future. Your successor, 2025, is shaping up to be quite the mixed bag — it’s like the year is expecting a baby, but no one knows if it’ll be a bundle of joy or a handful of trouble. Nigeria is trying really hard to stop putting all its eggs in the oil basket. There’s a lot of noise about agriculture, tech, and manufacturing stepping up. With this African Continental Free Trade Agreement (AfCFTA) getting more action, we might see Nigeria flexing as West Africa’s trade big brother. But let’s be honest — oil and gas aren’t going anywhere anytime soon. The Dangote Refinery finally kicking into gear might help us cut down on those expensive imported petroleum products. If it plays out right, that could mean fewer trade deficits and more jobs, which we desperately need. But you know how it is with oil — prices are like Lagos traffic, unpredictable and everywhere. Plus, the world’s moving towards greener energy, so we’ve got to figure out how to keep the money flowing long-term. Now, on the money front, I won’t sugarcoat it. Inflation and the exchange rate will probably keep dancing around, and not in a fun way. The Central Bank will try to keep things under control, but they’ll need serious foreign investment and more non-oil exports to make it work. The tech space is looking exciting, though. With all these young, sharp minds and everyone glued to their phones, Lagos and Abuja are becoming mini–Silicon Valley — fintech, e-commerce, aggrotech, you name it. Politically, Nigerians are still out here demanding real change. Anti-corruption will stay a hot topic — we’re all tired of the same old stories. There’s also this growing pressure for electoral reforms and better public services. Civil society is getting louder, and I’m here for it. But security? Whew. That’s going to be a big one. Between insurgency in the Northeast, banditry up North, and secessionist noise in the Southeast, the government has its hands full. It will take more than military action — they must dig into why these issues keep popping up. On top of that, some states are pushing harder for more control over their resources and policies. The whole decentralisation and restructuring debate might heat up. Meanwhile, you can bet politicians are already gearing up for 2027. Alliances will shift — it’s like watching chess, but with higher stakes. Look, Nigeria has its share of problems—inequality, environmental issues, governance struggles. But the potential? It’s huge. We’ve got the people and the energy, and if we can channel it right, the sky’s the limit. Here’s hoping 2025 is more of a blessing than a headache. As I look ahead to 2025, I do so with cautious optimism. While the road ahead remains uncertain, I am reminded that even in the darkest of times, resilience shines through. So, to everything we have passed through, thank you, 2024, for setting us free. 2025, if you’re reading, please be more liberal to us as a nation and as a people. May our leaders listen more and apply more wisdom. May 2025 usher in real hope, stability, and progress for Nigeria and the world. Wishing Nigerians a happy, peaceful, and prosperous new year. DAP .
Police arrested a “strong person of interest” Monday in the brazen Manhattan killing of UnitedHealthcare’s CEO after a quick-thinking McDonald’s employee in Pennsylvania alerted authorities to a customer who was found with a weapon and writings linking him to the ambush. The 26-year-old man had a gun believed to be the one used in the killing and writings suggesting his anger with corporate America, police officials said. He was taken into custody after police got a tip that he was eating at a McDonald’s in Altoona, Pennsylvania, NYPD Commissioner Jessica Tisch said at a news conference. Police identified the suspect as Luigi Mangione. Mangione was born and raised in Maryland, has ties to San Francisco, and his last known address is in Honolulu, Chief of Detectives Joseph Kenny said at a news briefing. Here's the latest: Asked if he needed a public defender, he asked if he could “answer that at a future date.” According to court documents, Mangione was sitting at a table in the rear of the McDonald's wearing a blue medical mask and looking at a silver laptop computer and had a backpack on the floor. When he pulled down his mask, Altoona police officers “immediately recognized him as the suspect” in the killing of UnitedHealthcare CEO Brian Thompson, the documents say. Asked for identification, Mangione provided officers with a fake ID — a New Jersey driver’s license bearing another name and the incorrect date of birth. When an officer asked Mangione if he’d been to New York recently, he “became quiet and started to shake,” the court documents say A police criminal complaint charged him with forgery, carrying firearms without a license, tampering with records or identification, possessing an instrument of crime and providing false identification to law enforcement. Video posted on the social platform X shows a handcuffed Mangione arriving at the Blair County Courthouse in Hollidaysburg, Pennsylvania. For example, it took about 10 months to extradite a man charged with stabbing two workers at the Museum of Modern Art in 2022. The suspect, Gary Cabana, was also arrested in Pennsylvania, where he was charged with setting his Philadelphia hotel room on fire. Cabana was sent back to New York after he pleaded guilty to an arson charge in Pennsylvania. Manhattan prosecutors could seek to expedite the process by indicting Mangione for Thompson’s killing while he’s still in custody of Pennsylvania authorities. They could then obtain what’s known as a supreme court warrant or fugitive warrant to get him back to New York. Freddie Leatherbury hasn’t spoken to Mangione since they graduated in 2016 from Gilman School in Maryland. He said Mangione was a smart, friendly and athletic student who came from a wealthy family, even by the private school’s standards. “Quite honestly, he had everything going for him,” Leatherbury said. Leatherbury said he was stunned when a friend shared the news of their former classmate’s arrest. “He does not seem like the kind of guy to do this based on everything I’d known about him in high school,” Leatherbury said. One of his cousins is Republican Maryland state legislator Nino Mangione, a spokesperson for the delegate’s office confirmed Monday. Luigi Mangione is one of 37 grandchildren of Nick Mangione Sr., according to a 2008 obituary. Mangione Sr. grew up poor in Baltimore’s Little Italy and rose after his World War II naval service to become a millionaire real estate developer and philanthropist, according to a 1995 profile by the Baltimore Sun. He and his wife Mary Cuba Mangione, who died in 2023, directed their philanthropy through the Mangione Family Foundation, according to a statement from Loyola University commemorating her death. They donated to a variety of causes, ranging from Catholic organizations to higher education to the arts. A man who answered the door to the office of the Mangione Family Foundation declined to comment Monday evening. Mangione Sr. was known for Turf Valley Resort, a sprawling luxury retreat and conference center outside Baltimore that he purchased in 1978. The father of 10 children, Nick Mangione Sr. prepared his five sons — including Luigi Mangione’s father, Louis Mangione — to help manage the family business, according to a 2003 Washington Post report. The Mangione family also purchased Hayfields Country Club north of Baltimore in 1986. On Monday afternoon, Baltimore County police officers had blocked off an entrance to the property, which public records link to Luigi Mangione’s parents. A swarm of reporters and photographers gathered outside the entrance. “Our hope is that today’s apprehension brings some relief to Brian’s family, friends, colleagues and the many others affected by this unspeakable tragedy,” a spokesperson for UnitedHealth Group said Monday. “We thank law enforcement and will continue to work with them on this investigation. We ask that everyone respect the family’s privacy as they mourn.” In an email to parents and alumni, Gilman headmaster Henry P.A. Smyth said it “recently” learned that Mangione, a 2016 graduate, was arrested in the CEO’s killing. “We do not have any information other than what is being reported in the news,” Smyth wrote. “This is deeply distressing news on top of an already awful situation. Our hearts go out to everyone affected.” Mangione, a high school valedictorian from a Maryland prep school, earned undergraduate and graduate degrees in computer science in 2020 from the University of Pennsylvania, a spokesman told The Associated Press on Monday. He had learned to code in high school and helped start a club at Penn for people interested in gaming and game design, according to a 2018 story in Penn Today, a campus publication. His posts also suggest that he belonged to the fraternity Phi Kappa Psi. They also show him taking part in a 2019 program at Stanford University, and in photos with family and friends in Hawaii, San Diego, Puerto Rico, the New Jersey shore and other destinations. Police said the suspect arrested Monday had a ghost gun , a type of weapon that can be assembled at home from parts without a serial number, making them difficult to trace. The critical component in building an untraceable gun is what’s known as the lower receiver. Some are sold in do-it-yourself kits and the receivers are typically made from metal or polymer. Altoona police say officers were dispatched to a McDonald’s on Monday morning in response to reports of a male matching the description of the man wanted in connection with the United Healthcare CEO’s killing in New York City. In a news release, police say officers made contact with the man, who was then arrested on unrelated charges. The Altoona Police Department says it’s cooperating with local, state, and federal agencies. “This just happened this morning. We’ll be working, backtracking his steps from New York to Altoona, Pennsylvania,” Kenny said. “And at some point we’ll work out through extradition to bring him back to New York to face charges here, working with the Manhattan district attorney’s office,” NYPD Chief of Detectives Joseph Kenny said. “As of right now, the information we’re getting from Altoona is that the gun appears to be a ghost gun that may have been made on a 3D printer, capable of firing a 9 mm round,” NYPD Chief of Detectives Joseph Kenny said at a news briefing. The document suggested the suspect had “ill will toward corporate America,” police added. Mangione, 26, was born and raised in Maryland, has ties to San Francisco, and his last known address in Honolulu, Chief of Detectives Joseph Kenny said at a news briefing. Police have arrested a 26-year-old with a weapon “consistent with” the gun used in the killing of UnitedHealthcare CEO Brian Thompson , New York City’s police commissioner says. Thompson , 50, died in a dawn ambush Wednesday as he walked to the company’s annual investor conference at Manhattan hotel. Thompson had traveled from Minnesota for the event. A man being questioned Monday in the killing of UnitedHealthcare CEO Brian Thompson had writings that appeared to be critical of the health insurance industry, a law enforcement official told The Associated Press. The man also had a gun thought to be similar to the one used in the killing, the official said. Police apprehended the man after receiving a tip that he had been spotted at a McDonald’s near Altoona, Pennsylvania, about 233 miles (375 kilometers) west of New York City, said the official, who wasn’t authorized to discuss details of the investigation and spoke to the AP on condition of anonymity. Along with the gun, police found a silencer and fake IDs, according to the official. — Michael R. Sisak That’s also according to the law enforcement official. — Michael R. Sisak That’s according to a law enforcement official. — Michael R. Sisak New York City Mayor Eric Adams is expected to address this development at a previously scheduled afternoon news briefing in Manhattan. While still looking to identify the suspect, the FBI has offered a $50,000 reward for information leading to his arrest and conviction. That’s on top of a $10,000 reward offered by the NYPD. That included footage of the attack, as well as images of someone at a Starbucks beforehand. Photos taken in the lobby of a hostel on Manhattan’s Upper West Side showed the person grinning after removing his mask, police said. NYPD dogs and divers returned to New York’s Central Park today while the dragnet for Thompson’s killer stretched into a sixth day. Investigators have been combing the park since the Wednesday shooting and searching at least one of its ponds for three days, looking for evidence that may have been thrown into it. Police say the shooter used a 9 mm pistol that resembled the guns farmers use to put down animals without causing a loud noise. Police said they had not yet found the gun itself. Ammunition found near Thompson’s body bore the words “delay,” “deny” and “depose,” mimicking a phrase used by insurance industry critics . A man with a gun thought to be similar to the one used in the killing of UnitedHealthcare CEO Brian Thompson was taken into police custody Monday for questioning in Pennsylvania, a law enforcement official told The Associated Press. The man is being held in the area of Altoona, Pennsylvania, about 233 miles (375 kilometers) west of New York City, the official said. The official was not authorized to discuss details of the ongoing investigation and spoke to the AP on condition of anonymity. The development came as dogs and divers returned Monday to New York’s Central Park while the dragnet for Thompson’s killer stretched into a sixth day. — Michael R. SisakPunjab Bandh Today: Farmers block roads at many places, trains cancelled; know what's open, what's closed
Lakers predicted to land $160 million versatile star via trade with Trail Blazers | Sporting NewsGiven Donald Trump’s history of making false or misleading statements — and his fixation on people’s physical appearance and size — it’s not a reach to think that he’d exaggerate his height. The president-elect has long claimed that he stands a commanding 6-foot-3, the Daily Mail reported . But the 78-year-old didn’t appear to measure up to that height, not while standing next to Prince William, who also is said to be 6-foot-3. The height discrepancy of an inch or two was visible when Trump met the heir to the British throne at the reopening of Notre Dame in Paris on Saturday. Trump and William appeared to enjoy a cordial exchange as they shook hands inside the cathedral, though the prince had to bend his head to meet the shorter man’s gaze. Trump and William later posed for photos at the residence of the British ambassador to France, as an exercise of soft diplomacy. Trump, again, looked somewhat shorter than the son of King Charles III and the late Princess Diana. Incidentally, the former reality TV star once claimed that he could have “nailed” Diana, and he also insisted in 2023 that William’s mother was among the celebrities who wanted to “kiss” up to him before he went into politics, People reported. The latter claim was fiercely denounced by Diana’s brother, Charles, 9th Earl Spencer, who said that the princess once likened Trump to a very bad sore in “the arse,” in the one and only time he said she mentioned him. It’s not likely that William brought up Trump’s boasts and insults at the Notre Dame event. After all, he was there to represent his father and British government. If there’s any consolation, he appeared to tower above the man who once spoke disrespectfully about his mother — even as he also appeared to have a friendly chat with the incoming U.S. president. Trump, for his part, praised William, quipping to reporters: “Good man, this one.” In a later interview with the New York Post , Trump had more positive things to say about the future king, saying they had a “great” 40-minute chat. “I asked him about his wife and he said she’s doing well,” Trump told the Post, referring to the Princess of Wales’ treatment over the past year for cancer. Trump also referred to Charles’ cancer battle, saying, “And I asked him about his father and his father is fighting very hard, and he loves his father and he loves his wife, so it was sad. We had a great talk for half an hour, a little more than half an hour. We had a great, great talk.” Meanwhile, it’s possible that Trump has become shorter than his stated 6-foot-3. It’s known that men can begin to shrink as they age. Some health experts say that men can lose an inch in height between ages 30 and 70, and lose another inch after they turn 80. Trump is almost 80. According to the Daily Mail, Trump remains sensitive about his height, as he has boasted about the beauty and stature of his oldest daughter Ivanka Trump . He also has expressed pride in the fact that his youngest son, 18-year-old Barron, has grown to a towering 6-foot-7. But “rumors have long swirled” that Trump relies on “lifters” — insoles in shoes — or taller heels to give him an additional height, the Daily Mail reported. Unfortunately for Trump, he has begun to appear shorter than he might like when he has recently posed besides other world figures and business leaders, according to the Daily Mail. For example, Trump didn’t look much taller standing next to the 5-foot-7 French President Emmanuel Macron at the Elysee Palace on Saturday. Trump also has been somewhat dwarfed physically by his fervent new supporter, the 6-foot-2 Elon Musk, the Daily Mail said. When the Tesla and Space X founder joined Trump at his campaign appearances, or when he hosted the 47th president to the Nov. 19 launch of his SpaceX Starship rocket, he stood “significantly” taller than the new president, the Daily Mail reported. ©2024 MediaNews Group, Inc. Visit at mercurynews.com. Distributed by Tribune Content Agency, LLC.
Southern California jumped to No. 4 in The Associated Press women's college basketball poll on Monday after edging UConn. The Trojans moved up three spots in the AP Top 25 after beating the then-No. 4 Huskies 72-70 on Saturday night in a rematch of last season's Elite Eight game that UConn won. "It feels great to get the dub always," USC star JuJu Watkins said after the victory. "I think it hit a little different knowing the history of last year and how they sent us home." This was the Trojans' first win ever over UConn. "This is a really significant win, and it's a really significant win because of the stature of UConn's program and what Geno Auriemma has done for our sport," USC coach Lindsay Gottlieb said. "It doesn't matter to me that they haven't won a championship in a couple years. There's still a way that they prepare, a way that they play, that makes you better, and it made us better." UCLA, South Carolina and Notre Dame remained the top three teams. The Bruins received 30 of the 32 first-place votes from a national media panel. The Gamecocks and the Fighting Irish each got one first-place vote. UConn fell to seventh behind Texas and LSU. Maryland, Oklahoma and Ohio State rounded out the top 10 teams. Duke dropped five spots to No. 14 after losing to South Florida on Saturday. The Blue Devils' other two losses this season were to Maryland and South Carolina. The Bulls are 7-6 on the season, with four of those losses coming against ranked opponents (UConn, Louisville, TCU and South Carolina). Alabama jumped back into the poll at No. 20 two weeks after falling out. The Crimson Tide had an impressive 82-67 victory over Michigan State, handing the Spartans their first loss of the season. It was Alabama's first victory over a ranked opponent this year. The Southeastern Conference has eight teams in the poll this week with Alabama's return. The Big Ten is next with seven. The ACC has six while the Big 12 has three and the Big East one. No. 23 Michigan at No. 4 USC, Sunday. The Wolverines start Big Ten play with a trip to Los Angeles to face the Trojans on Sunday and then the Bruins a few days later. Coach Kim Barnes Arico's young team is off to a 10-2 start. Get local news delivered to your inbox!
Graph Database Market Size & Trends To 2030 11-26-2024 08:17 PM CET | IT, New Media & Software Press release from: Prudent Markets Graph Database Market The Graph Database Market 2024 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Graph Database market. This report explores all the key factors affecting the growth of the global Graph Database market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis. The report concludes with the profiles of major players in the Graph Database market are: ArangoDB, Cambridge Semantics, DataStax, Franz Inc., International Business Machines Corporation, MarkLogic, Memgraph, Microsoft, Neo Technology, Inc., OpenLink Software, Oracle, OrientDB, Sparcity Technologies, Teradata Corporation, TIBCO Software, TigerGraph Discover Who You Really Compete Against In The Marketplace, Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/23257/ Graph Database Market Segmentation are: Type (Resource Description Framework, and Property Graph); By Component (Tools, and Services); By Deployment type (Cloud, and On-Premises); By Application (Customer Analytics, Risk Management and Fraud Detection, Recommendation Engines, and Other Applications); By (Large Enterprise, and Small and Medium-Sized Enterprise); By Industry Vertical (BFSI, Telecom and IT, Healthcare and Lifesciences, and Others); By Geography (North America, Asia-Pacific, Europe, Middle East & Africa, and South America), Industry Trends, Estimation & Forecast, 2018 2026 The research report offers a comprehensive picture of the Graph Database market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market. About Graph Database Market The Global Graph Database market is expected to reach $3.5 billion by 2026, with a projected CAGR of 23.6% during the forecast period. A graph database is one that stores data in terms of entities and the relationships between entities. The systems are commonly built to be used in transactional systems. The graph relates the data items in the store to a collection of nodes and edges; the edges representing the relationships between the nodes. These benefits and systems have the ability for scaling and handling naturally large data sets. Graph database is engineered with transactional integrity and operational availability, designed to deliver high-level transactional performance. The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Graph Database report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026. The Graph Database market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Graph Database report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porters Five Forces, and others are considered by the analysts while preparing the report. Scope and Segmentation of the Market Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs. Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/23257/ The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Graph Database Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market. Regional Analysis for Graph Database Market: • North America (the USA and Canada) • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) • Latin America (Brazil, Mexico and Rest of Latin America) • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa) TO KNOW MORE ABOUT COVID-19 IMPACT @ https://www.prudentmarkets.com/sample-request/23257/ Strategic Points Covered in Table of Content of Global Graph Database Market: Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Graph Database market Chapter 2: Exclusive Summary - the basic information of the Graph Database Market. Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Graph Database Chapter 4: Presenting the Graph Database Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis. Chapter 5: Displaying the by Type, End User and Region/Country Chapter 6: Evaluating the leading manufacturers of the Graph Database market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Why should you purchase this report? -Prudent Markets provides the vital historical and analysis data of global Graph Database market. -The report provides the entire assessment of the future market and altering market scenario or behavior. -All the business decision could be backed through the several strategic business methodologies offered in the report. -An extra edge in the competitive market could be obtained from this elaborative research report -The report offers all the competitive landscape, growth drivers, applications, market dynamics, and other necessary details as well. For In-Depth Competitive Analysis - Purchase this Report now at a Complete Table of Contents (Single User License) @ https://www.prudentmarkets.com/checkout/?id=23257&license_type=su Free Customization on the basis of client requirements on Immediate purchase: 1- Free country-level breakdown of any 5 countries of your interest. 2- Competitive breakdown of segment revenue by market players. Customization of the Report: This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements. Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis. In conclusion, the Graph Database Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report. https://www.linkedin.com/pulse/assessing-impact-growth-consumer-behavior-yylzc/ https://www.linkedin.com/pulse/comprehensive-review-household-massage-cushion-tfdkc/ https://www.linkedin.com/pulse/comprehensive-review-heel-cups-market-current-trends-p7i4e/ https://www.linkedin.com/pulse/analysis-lift-reflux-valves-market-its-j73te/ https://www.linkedin.com/pulse/analysis-low-voltage-motor-soft-starter-market-its-ykjdc/ Contact Us: Allan Carter Andheri, Maharashtra, 400102 USA/Canada(Toll Free): 1800-601-6071 Direct Line: +91 83560 50278 Mail: sales@prudentmarkets.com Web: www.prudentmarkets.com About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.
Opioid Withdrawal Syndrome Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, Therapies, Mechanism of Action, Route of Administration, and Developments | Chiesi Farmaceutici S.p.A., BioXcel Therapeutics, Braeburn Pharmaceuticals, Indivior 11-22-2024 09:25 PM CET | Health & Medicine Press release from: DelveIinsight Business Research (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Opioid Withdrawal Syndrome pipeline constitutes 4+ key companies continuously working towards developing 4+ Opioid Withdrawal Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Opioid Withdrawal Syndrome Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Opioid Withdrawal Syndrome Market. The Opioid Withdrawal Syndrome Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. Some of the key takeaways from the Opioid Withdrawal Syndrome Pipeline Report: https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr •Companies across the globe are diligently working toward developing novel Opioid Withdrawal Syndrome treatment therapies with a considerable amount of success over the years. •Opioid Withdrawal Syndrome companies working in the treatment market are Chiesi Farmaceutici S.p.A., BioXcel Therapeutics, Braeburn Pharmaceuticals, Indivior, and others, are developing therapies for the Opioid Withdrawal Syndrome treatment •Emerging Opioid Withdrawal Syndrome therapies in the different phases of clinical trials are- CHF-6563, BXCL501, BRIXADI (buprenorphine), SUBLOCADE (buprenorphine), CAM2038, and others are expected to have a significant impact on the Opioid Withdrawal Syndrome market in the coming years. •In October 2024, ANANDA Scientific Inc., a biopharmaceutical company focused on research, today announced the initiation of a clinical trial to evaluate NantheiaTM ATL5. This investigational drug combines cannabidol with ANANDA's proprietary delivery technology and is co-administered with delta-9-tetrahydrocannabinol (THC). The trial aims to assess its potential effectiveness in treating co-occurring opioid use disorder (OUD) and chronic pain. (Clinical Trials.gov Identifier: NCT06544291) Opioid Withdrawal Syndrome Overview Opioid Withdrawal Syndrome is a condition that occurs when individuals who are dependent on opioids abruptly reduce or stop their use. It results from the body's adaptation to prolonged opioid use, leading to physical dependence. Symptoms of withdrawal can range from mild to severe and typically include anxiety, agitation, muscle aches, sweating, nausea, vomiting, diarrhea, and insomnia. While the syndrome itself is not life-threatening, it can be extremely uncomfortable and may lead to relapse if not managed properly. Treatment often includes supportive care, medications like buprenorphine or methadone, and behavioral therapy to aid recovery. Get a Free Sample PDF Report to know more about Opioid Withdrawal Syndrome Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Emerging Opioid Withdrawal Syndrome Drugs Under Different Phases of Clinical Development Include: •CHF-6563: Chiesi Farmaceutici S.p.A. •BXCL501: BioXcel Therapeutics •BRIXADI (buprenorphine): Braeburn Pharmaceuticals •SUBLOCADE (buprenorphine): Indivior •CAM2038: Braeburn Pharmaceuticals Opioid Withdrawal Syndrome Route of Administration Opioid Withdrawal Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as •Oral •Parenteral •Intravenous •Subcutaneous •Topical Opioid Withdrawal Syndrome Molecule Type Opioid Withdrawal Syndrome Products have been categorized under various Molecule types, such as •Monoclonal Antibody •Peptides •Polymer •Small molecule •Gene therapy Opioid Withdrawal Syndrome Pipeline Therapeutics Assessment •Opioid Withdrawal Syndrome Assessment by Product Type •Opioid Withdrawal Syndrome By Stage and Product Type •Opioid Withdrawal Syndrome Assessment by Route of Administration •Opioid Withdrawal Syndrome By Stage and Route of Administration •Opioid Withdrawal Syndrome Assessment by Molecule Type •Opioid Withdrawal Syndrome by Stage and Molecule Type DelveInsight's Opioid Withdrawal Syndrome Report covers around 4+ products under different phases of clinical development like •Late-stage products (Phase III) •Mid-stage products (Phase II) •Early-stage product (Phase I) •Pre-clinical and Discovery stage candidates •Discontinued & Inactive candidates •Route of Administration Further Opioid Withdrawal Syndrome product details are provided in the report. Download the Opioid Withdrawal Syndrome pipeline report to learn more about the emerging Opioid Withdrawal Syndrome therapies at: https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key companies in the Opioid Withdrawal Syndrome Therapeutics Market include: Key companies developing therapies for Opioid Withdrawal Syndrome are - Novartis, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals, MediciNova, Alkermes, Inc., Trevena, Aphios, Kyowa kirin, Gamida-Cell, BioDelivery Sciences International, Inc., and others. Opioid Withdrawal Syndrome Pipeline Analysis: The Opioid Withdrawal Syndrome pipeline report provides insights into •The report provides detailed insights about companies that are developing therapies for the treatment of Opioid Withdrawal Syndrome with aggregate therapies developed by each company for the same. •It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Opioid Withdrawal Syndrome Treatment. •Opioid Withdrawal Syndrome key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. •Opioid Withdrawal Syndrome Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. •Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Opioid Withdrawal Syndrome market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Download Sample PDF Report to know more about Opioid Withdrawal Syndrome drugs and therapies- https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Opioid Withdrawal Syndrome Pipeline Market Drivers •Rising Prevalence of Opioid Addiction, Awareness Programs, Advancements in Treatments, Supportive Regulations, Integration of Telemedicine, are some of the important factors that are fueling the Opioid Withdrawal Syndrome Market. Opioid Withdrawal Syndrome Pipeline Market Barriers •However, Stigma Associated with Addiction, High Treatment Costs, Limited Access in Rural Areas, Regulatory Challenges, and other factors are creating obstacles in the Opioid Withdrawal Syndrome Market growth. Scope of Opioid Withdrawal Syndrome Pipeline Drug Insight •Coverage: Global •Key Opioid Withdrawal Syndrome Companies: Chiesi Farmaceutici S.p.A., BioXcel Therapeutics, Braeburn Pharmaceuticals, Indivior, and others •Key Opioid Withdrawal Syndrome Therapies: CHF-6563, BXCL501, BRIXADI (buprenorphine), SUBLOCADE (buprenorphine), CAM2038, and others •Opioid Withdrawal Syndrome Therapeutic Assessment: Opioid Withdrawal Syndrome current marketed and Opioid Withdrawal Syndrome emerging therapies •Opioid Withdrawal Syndrome Market Dynamics: Opioid Withdrawal Syndrome market drivers and Opioid Withdrawal Syndrome market barriers Request for Sample PDF Report for Opioid Withdrawal Syndrome Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Table of Contents 1. Opioid Withdrawal Syndrome Report Introduction 2. Opioid Withdrawal Syndrome Executive Summary 3. Opioid Withdrawal Syndrome Overview 4. Opioid Withdrawal Syndrome- Analytical Perspective In-depth Commercial Assessment 5. Opioid Withdrawal Syndrome Pipeline Therapeutics 6. Opioid Withdrawal Syndrome Late Stage Products (Phase II/III) 7. Opioid Withdrawal Syndrome Mid Stage Products (Phase II) 8. Opioid Withdrawal Syndrome Early Stage Products (Phase I) 9. Opioid Withdrawal Syndrome Preclinical Stage Products 10. Opioid Withdrawal Syndrome Therapeutics Assessment 11. Opioid Withdrawal Syndrome Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. Opioid Withdrawal Syndrome Key Companies 14. Opioid Withdrawal Syndrome Key Products 15. Opioid Withdrawal Syndrome Unmet Needs 16 . Opioid Withdrawal Syndrome Market Drivers and Barriers 17. Opioid Withdrawal Syndrome Future Perspectives and Conclusion 18. Opioid Withdrawal Syndrome Analyst Views 19. Appendix 20. About DelveInsight Related Reports: Opioid Withdrawal Syndrome Market https://www.delveinsight.com/report-store/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Opioid Withdrawal Syndrome Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), Opioid Withdrawal Syndrome Epidemiology https://www.delveinsight.com/report-store/opioid-withdrawal-syndrome-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Opioid Withdrawal Syndrome Epidemiology Forecast to 2034' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Latest Reports: •Pd-1 & Pdl1 Market: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape •Cervical Dysplasia Market: https://www.delveinsight.com/report-store/cervical-dysplasia-market-insights •Hypogonadism Market: https://www.delveinsight.com/report-store/hypogonadism-market •Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market •Non-hodgkin's Lymphoma Market: https://www.delveinsight.com/report-store/non-hodgkins-lymphoma-market •Substance Use Disorder Market: https://www.delveinsight.com/report-store/substance-use-disorder-market Contact Us: Gaurav Bora gbora@delveinsight.com +14699457679 Healthcare Consulting https://www.delveinsight.com/consulting-services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. This release was published on openPR.‘Sudden death’ occurred in water off Rocky Point Park over weekend, police sayCowboys' Mike McCarthy Reacts to Jerry Jones' Comments About Possible New Contract